Patent · US Active

Pyrimidine amide compounds as PGDS inhibitors

US8202863B2 · kind B2 · utility

2Cited by

0References

28Claims

0Family size

Assignee

Aventis Pharmaceuticals Inc. · US

Inventors

Suzanne C. Aldous · Gillette, US
John Ziqi Jiang · Fryeburg, US
Jinqi Lu · Green Brook, US
Liang Ma · Fryeburg, US
Lan Mu · Berkeley Heights, US
Harry R. Munson, Jr. · Durham, US
Jeffrey S. Sabol · Loveland, US
Sukanthini Thurairatnam · Bedminster, US
Christopher L. VANDEUSEN · Hopkinton, US

Key dates

Filing date	Apr 4, 2008
Grant date	Jun 19, 2012
Priority date	—
Expiry date	Oct 2, 2028

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D413/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention is directed to a compound of formula (I):wherein R1, R2, R3 and L1 are as defined herein, a pharmaceutical composition comprising the compound, and the use of the compound to treat allergic and/or inflammatory disorders, particularly disorders such as allergic rhinitis, asthma and/or chronic obstructive pulmonary disease (COPD).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.